FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

La Vita Compounding Pharmacy Methyl Folate CA+ 1mg/ml Injection w/Pres Recall

Methyl Folate CA+ 1mg/ml Injection w/Pres

La Vita Compounding Pharmacy, LLC · San Diego, CA

Risk level
Class II
Reported by FDA
Jul 25, 2018
Recall ID
D-0922-2018
Check your lot numberHow we source this data

Summary

La Vita Compounding Pharmacy recalled Methyl Folate CA+ 1mg/ml Injection w/Pres starting Jun 25, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0922-2018 on Jul 25, 2018. Reason: Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile. Status: Terminated.

Why it was recalled

Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.

Product description

Methyl Folate CA+ 1mg/ml Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500

Lot numbers, UPCs & expiration codes

Lot #: 140089@1, Exp 08/06/2018; 141968@6, Exp 09/03/2018; 143381@2, Exp 09/24/2018; 145265@13, Exp 10/22/2018; 146479@6, Exp 11/12/2018

Where it was sold

Product was distributed to patients via patient specific prescription only in CA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0922-2018
Classification
Class II
Status
Terminated
Recall initiated
Jun 25, 2018
FDA report date
Jul 25, 2018
Quantity
17,610 mL total dispensed in 10 mL and 30 mL vials
Recall type
Voluntary: Firm initiated
Recalling firm
La Vita Compounding Pharmacy, LLC

Original FDA data

Every field from FDA enforcement report D-0922-2018, exactly as published.

Show all FDA fields
City
San Diego
State
CA
Status
Terminated
Country
United States
Event ID
80416
Address
3978 Sorrento Valley Blvd Ste 300
Code information
Lot #: 140089@1, Exp 08/06/2018; 141968@6, Exp 09/03/2018; 143381@2, Exp 09/24/2018; 145265@13, Exp 10/22/2018; 146479@6, Exp 11/12/2018
Postal code
92121-1436
Report date
Jul 25, 2018
Product type
Drugs
Recall number
D-0922-2018
Classification
Class II
Recalling firm
La Vita Compounding Pharmacy, LLC
Product quantity
17,610 mL total dispensed in 10 mL and 30 mL vials
Termination date
Jan 18, 2019
Reason for recall
Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methyl Folate CA+ 1mg/ml Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500
Distribution pattern
Product was distributed to patients via patient specific prescription only in CA.
Recall initiation date
Jun 25, 2018
Initial firm notification
Letter
Center classification date
Jul 13, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0922-2018, published Jul 25, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls